Shareholders

Shareholders in Chordate Medical Holding AB per 2019-12-31

Shareholder Number of shares Votes and capital %
Gert Purkert incl company (Tiven GmbH) 4 759 798 13,4%
Henrik Rammer 3 669 798 10,4%
HAWOC Investment AB 3 000 000 8,5%
Tommy Hedberg 2 958 897 8,4%
Lars Ingvarsson incl company (Sifonen & Klittersand) 2 455 785 6,9%
Vedise Hospitel S.p.A 2 137 320 6,0%
Magnum Invest AB 1 850 000 5,2%
Victoria Gutenbrant 1 809 200 5,1%
Fredrik Sjödin  1 616 712 4,6%
Vilhelm Sundström 1 180 152 3,3%
Övriga aktieägare 9 960 910 28,1%
Total 35 398 572 100,0%

We are a Swedish medical technology company listed on NGM Nordic SME.

Chordate has spent more than 10 years developing the Kinetic Oscillation Stimulation, K.O.S, a technique for treating rhinitis and migraine. We have a patent on K.O.S in the EU and the United States, as well as many other countries.

We have answered frequently asked questions in our FAQ. If you want to know more, please get in touch.

IR contact